Asian Institute of Nephrology and Urology 
Dealstreet

Khaitan advises Asian Institute of Nephrology and Urology on sale of majority stake to Asia Healthcare Holdings

The deal amount is valued at ₹600 crore.

Bar & Bench

The Asian Institute of Nephrology and Urology Private Limited ("AINU") has sold the majority stake by way of secondary sale and primary issuance of shares to Asia Healthcare Holdings Pte. Ltd. for an overall deal value of ₹600 crore.

Khaitan & Co advised AINU, the selling shareholders (including the promoters) and the exiting fund, HealthQuad Fund I in this transaction.

The core team consisted of Mayank Singh (Partner), Kevin Peter (Counsel), Kairavi Shah (Principal Associate), Esha Chauhan (Senior Associate), Hitakshi Mahendru (Senior Associate) with closing assistance from Mohnish Singh (Associate).

Mayank Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Haq and the million-dollar FAQ: Why Indian divorce law still fails the global gender justice test

KPMG cloned Digi Yatra app during illegal visit to Hyderabad office: Data Evolve tells Delhi High Court

Kerala High Court sets one-week deadline for State to frame guidelines on appointment of Public Prosecutors

If special revision is being done, the process needs to be justified: Supreme Court in Bihar SIR challenge

Aryan Khan’s show exposes Bollywood; Sameer Wankhede shouldn’t be sensitive: Netflix to Delhi HC

SCROLL FOR NEXT